Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Comabella

Showing results (71-80 of 263) with videos related to

Pageof 27
Sort By:
Scientific Reports|April 30, 2020
Chitinase 3-like 1 is neurotoxic in primary cultured neuronsClara Matute-Blanch, Laura Calvo-Barreiro, Iria Carballo-Carbajal, et al.
Plos One|October 23, 2008
Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphismsManuel Comabella, David W Craig, Montse Camiña-Tato, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 9, 2024
Cytomegalovirus immune responses are associated with lower serum NfL and disability accumulation risk at multiple sclerosis onsetJan D Lünemann, Augusto Sao Avilés, Mar Tintoré, et al.
Journal of Neurology|March 3, 2006
TNF-alpha converting enzyme (TACE) protein expression in different clinical subtypes of multiple sclerosisManuel Comabella, Cristina Romera, Montse Camiña, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 29, 2016
The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?Patrick Vermersch, Thomas Berger, Ralf Gold, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 21, 2022
Serum Levels of CXCL13 Are Associated With Teriflunomide Response in Patients With Multiple SclerosisNicolás Fissolo, Agustin Pappolla, Jordi Rio, et al.
Annals of Neurology|March 13, 2010
Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosisJan D Lünemann, Mar Tintoré, Brady Messmer, et al.
Journal of Neuroinflammation|June 26, 2012
Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitisNicolás Fissolo, Carme Costa, Ramil N Nurtdinov, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 7, 2022
Increased cytomegalovirus immune responses at disease onset are protective in the long-term prognosis of patients with multiple sclerosisManuel Comabella, Mar Tintore, Augusto Sao Avilés, et al.
Frontiers in Immunology|February 18, 2026
Impact of preanalytical factors on blood CHI3L1 levelsManuel Comabella, Lucía Gutierrez, Mireia Castillo, et al.
Pageof 27

Showing results (71-80 of 263) with videos related to

Sort By:
Pageof 27
Scientific Reports|April 30, 2020
Chitinase 3-like 1 is neurotoxic in primary cultured neuronsClara Matute-Blanch, Laura Calvo-Barreiro, Iria Carballo-Carbajal, et al.
Plos One|October 23, 2008
Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphismsManuel Comabella, David W Craig, Montse Camiña-Tato, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 9, 2024
Cytomegalovirus immune responses are associated with lower serum NfL and disability accumulation risk at multiple sclerosis onsetJan D Lünemann, Augusto Sao Avilés, Mar Tintoré, et al.
Journal of Neurology|March 3, 2006
TNF-alpha converting enzyme (TACE) protein expression in different clinical subtypes of multiple sclerosisManuel Comabella, Cristina Romera, Montse Camiña, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 29, 2016
The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?Patrick Vermersch, Thomas Berger, Ralf Gold, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 21, 2022
Serum Levels of CXCL13 Are Associated With Teriflunomide Response in Patients With Multiple SclerosisNicolás Fissolo, Agustin Pappolla, Jordi Rio, et al.
Annals of Neurology|March 13, 2010
Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosisJan D Lünemann, Mar Tintoré, Brady Messmer, et al.
Journal of Neuroinflammation|June 26, 2012
Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitisNicolás Fissolo, Carme Costa, Ramil N Nurtdinov, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 7, 2022
Increased cytomegalovirus immune responses at disease onset are protective in the long-term prognosis of patients with multiple sclerosisManuel Comabella, Mar Tintore, Augusto Sao Avilés, et al.
Frontiers in Immunology|February 18, 2026
Impact of preanalytical factors on blood CHI3L1 levelsManuel Comabella, Lucía Gutierrez, Mireia Castillo, et al.
Pageof 27